About

Boyi Group

Changzhou Boyi Bio Group

Make products more valuable

Group Profile
The total investment of the Changzhou Boyi Biotech Group ("Boyi Biotech") project is RMB 300 million. The project is located on Changyang Road, Xitaihu Industrial Park, Wujin District, Changzhou City, covering an area of ​​about 45 mu. It is planned to build 45,000 square meters of office, R&D and production buildings, and 10 new automated production lines. It is expected to be put into production in the second half of 2024. Boyi Biotech will be committed to developing upstream and downstream tool products for life sciences, realizing product value for customers with professional technology and high-quality services, and taking providing customers with more choices as its mission, and contributing to the development of life sciences and human health.

300

Million/Investment

45

Mu/Group Land

10

Production Line

Boyi Group Industries

Subsidiary Company

swiper5 item icon1

—（Industrial resin）

swiper5 item icon2

—（In vitro diagnostics）

swiper5 item icon3

—（Life sciences）

swiper5 item img1

Professional Manufacturer of Chromatography Resin

Changzhou Tiandi Renhe Biotechnology Co., Ltd. was established in 2013. It is a high-tech enterprise dedicated to the research and development and production of high-quality biological microsphere purification media and supporting consumables and instruments. The company's current products mainly include independently developed and produced agarose microsphere-based labeled protein affinity fillers, antibody affinity fillers, pre-activated fillers, ion exchange fillers, hydrophobic fillers, molecular sieves and purification equipment and consumables.
Read More
swiper5 item img2

Making in vitro test reagent production easier

Changzhou Boyi Biotechnology Co., Ltd. is a technology-based enterprise based in the in vitro diagnostic industry, providing key raw materials and overall solutions for biomedical customers. The company focuses on diagnostic microspheres, test raw materials and quality control products and other core raw materials in the in vitro diagnostic industry. It has established a professional team of talents consisting of cross-disciplinary disciplines such as polymer material science, immunology, biomedical engineering, clinical laboratory medicine, molecular biology and biochemistry, creating core technological advantages, establishing advanced technology platforms and innovative R&D systems.
Read More
swiper5 item img3

Faster! Easier!

The ACE brand under Changzhou Boyi Biotechnology Co., Ltd. is oriented to the field of life sciences. Its mission is to save precious time for scientific researchers and to promote the rapid development of the biological industry. It focuses on the development and application of high-efficiency biological reagents and instruments, and is committed to optimizing conventional biological experimental processes, improving work efficiency, and providing high-efficiency, high-quality, and cost-effective products for the majority of biological researchers.
Read More
Boyi News Center
  • News
  • Group Dynamics
    • The groundbreaking ceremony of Changzhou Boyi Biotech was successfully concluded
    The groundbreaking ceremony of Changzhou Boyi Biotech was successfully concluded

    On the morning of April 19, the groundbreaking ceremony for the Changzhou Boyi Biological Group Microsphere and Related Core Biological Preparation R&D and Industrialization Base Project was grandly held at the West Taihu Industrial Park. Yun Qicheng, deputy secretary of the Wujin District Party Committee and district mayor, Xu Jun, deputy district mayor and secretary of the Party Working Committee of the West Taihu Science and Technology Industrial Park, leaders of the District Development and Reform Bureau, District Science and Technology Bureau, District Industry and Information Technology Bureau, District Housing and Urban-Rural Development Bureau, District Commerce Bureau, District Administrative Approval Bureau, District Natural Resources and Planning Bureau, and investors of Boyi Biological Group were invited to attend.

    News
    Chen Jinhu, secretary of the Changzhou Municipal Party Committee, and his delegation inspected the Boyi Biological Project site
    2024/03/13

    In November 2023, Changzhou City issued the "10 Measures for Synthetic Biology" to support the high-quality development of the synthetic biology industry, accelerate the improvement of R&D and innovation levels, and seize the future growth pole. On December 6, at the site of the "Bio-microspheres and Related Core Reagents R&D and Industrialization Base" of the Boyi Biological Construction Project, Changzhou Municipal Party Committee Secretary Chen Jinhu learned in detail about the project construction progress, corporate innovation and R&D, and market prospects.

    Group Dynamics
  • Boyi 10th Anniversary Celebration
    Boyi 10th Anniversary Celebration

    As time goes by, we usher in a new year. On January 19, 2024, Boyi Bio held its annual meeting, and all employees gathered together to witness this grand event.

  • Successfully passed ISO13485 medical device quality management system certification
    Successfully passed ISO13485 medical device quality management system certification

    In July 2023, Changzhou Boyi Biotechnology Co., Ltd. successfully passed the ISO13485:2016/GB/T42061-2022 medical device quality management system certification and obtained the certificate after strict review by the Beijing Guoyixie Huaguang Certification Review Expert Group.